Biomarker ID | 1176 |
PMID | 23861782 |
Year | 2013 |
Biomarker | Prostate Health Index (phi) |
Biomarker Basis | Concentration Based |
Biomolecule | mRNA |
Source | Serum |
Subjects | Humans |
Regulation | Upregulated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | Base Model + phi: OR: [1.05 (95% CI: 1.03 to 1.07)] |
Effect on Pathways | NA |
Experiment | Prostate Cancer Vs No evidence of Maligancy |
Type of Biomarker | Diagnostic |
Cohort | Population of 300, such that 108 had Prostate Cancer and 192 had no evidence of malignancy were considered for the study |
Senstivity | NA |
Specificity | NA |
AUC | 0.77 (95% CI: 0.72 to 0.83) |
Accuracy | NA |
Level Of Significance | p <0.001 |
Method Used | Assays |
Clinical | No |
Remarks | Patients with PSA in range 2-10ng/ml were chosen for this analysis |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |